FDA Approves New Drug for Deadly Lung Cancer
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer....
The U.S. Food and Drug Administration on Thursday approved a new drug to treat patients with an advanced form of deadly lung cancer....
With a history of precision manufacturing, a thriving talent pool and high quality of life, Wisconsin has established itself as a biohealth hub....
There has been a real push among the industry to improve diversity in trials. The FDA report shows diversity statistics from US trials....
The University of Wisconsin Carbone Cancer Center is now home to the Initiative for Theranostics and Particle Therapy....
Epic is rolling out a new personalized care data tool, which aims to give doctors crucial patient insights. ...
Insist on proper care, ask critical questions about treatments, and push firmly but respectfully for my doctors to truly listen to me as the expert on my own condition. No one understands what a patient is going through better than the patient themselves....
Participation in cancer treatment clinical trials was higher than historical estimates, according to a national sample of data from the Commission on Cancer....
Every year we offer seed grants to support budding research projects -- something related to primary care or hospital medicine -- helping to foster collaborations and new ways of thinking about the care we provide....
The increasing number of diagnoses among young people (those 49 and under) is a worrisome trend that isn’t understood by researchers. Young people diagnosed with colorectal cancer often have an advanced stage of the disease, posing significant challenges for effective treatment. ...
Bart Bortz, of Sun Prairie, Wis., defied the odds in his battle against cancer, thanks to groundbreaking research and treatment at UW Health’s Carbone Cancer Center....